Selexis SA

Selexis SA, is the global leader in cell line development with best-in-class modular technology that enable the life sciences industry to rapidly discover, develop and commercialize innovative biologic medicines and vaccines. Our global partners, representing the complete spectrum of life science enterprises — from research laboratories and biotech startups to Big Pharma — are utilizing Selexis technologies to advance more than 164 products in preclinical and clinical development and 10 commercial products.

Selexis is a science-driven organization, founded on the academic interests and discoveries of its core scientific team in molecular biology, cellular physiology, and genetic engineering, and is committed to the application of these insights and methods to continuous process improvement and practical problem-solving through close interaction with its industry clients and collaborators.